Cancer of the esophagus claims more than 400,000 lives around the world each year. With no efficient, reliable method of screening for the disease, by the time symptoms become apparent, it’s often too late to save the patient. A Johns Hopkins researcher who has devoted his career to the detection and prevention of esophageal cancer […]
Home » Colon Cancer »
How breast cancer avoids immune system detection
Recent breakthroughs in immunotherapy are making a huge difference in treating some forms of cancer, especially metastatic cancer. But breast cancer has proven a tricky foe for this new therapy, and an interdisciplinary team of FSU researchers is now a little bit closer to figuring out why. Associate Professor of Statistics Jinfeng Zhang, Professor of […]
Breakthrough in cancer diagnosis: blood test to detect all cancers at the same time within a few minutes
Can this revolutionize the fast test, the cancer diagnosis? A new type of blood or tissue test can diagnose within just ten minutes cancer. As the basis of a newly-discovered structure of DNA, which seems to be the case with all types of cancer to occur. The Test detects quickly and easily, whether these structures […]
Imaging collaboration sheds new light on cancer growth
Walter and Eliza Hall Institute researchers have uncovered new insights into how the normal controls on cell growth are lost in cancer cells, leading to rapid tumour expansion. The findings could help researchers predict how cancer cells respond to chemotherapy and improve our understanding of how cancer evolves. Published in the journal Cell Cycle, the […]
Lung cancer drug could be repurposed to target ‘zombie’ proteins linked to leukemia
A new study by scientists at the University of Liverpool highlights how a clinically-approved lung cancer drug could potentially be ‘repurposed’ to design new treatments for future cancer therapies. The research, published in Science Signaling, focuses on a protein called TRIB2, which is linked to promoting survival and drug resistance in solid tumours and blood […]
Nanoparticle therapeutic restores function of tumor suppressor in prostate cancer
Think of it as a cancer therapy zag instead of a zig. While many groups are developing cancer therapies to target proteins and pathways that are highly active in cancer cells, a team of investigators from Brigham and Women’s Hospital and Boston Children’s Hospital, with collaborators at Memorial Sloan Kettering Cancer Center, is taking a […]
Novel role of protein in important pathways that lead to cancer malignancy
Japanese researchers have revealed for the first time that a specific protein plays a critical role in the development and metastasis of highly aggressive prostate and breast cancer cells. The study reports that large amounts of the fatty acid-binding protein 5 (FABP5), a kind of transport protein for fatty acids, promotes processes associated with cancer […]
Common skin cancer can signal increased risk of other cancers
People who develop abnormally frequent cases of a skin cancer known as basal cell carcinoma appear to be at significantly increased risk for the development of other cancers, including blood, breast, colon and prostate cancers, according to a preliminary study by researchers at the Stanford University School of Medicine. The increased susceptibility is likely caused […]
Discovery could lead to better treatment for leukemia
Previous research has revealed that patients with acute myeloid leukemia who also have a particular mutation in a gene called NPM1 have a higher rate of remission with chemotherapy. About one-third of leukemia patients possess this favorable mutation, but until now, how it helps improve outcomes has remained unknown. Scientists from the University of Illinois […]